Theseinitial studies concretely demonstrated that PPARγ acts as a tumor suppressor in a cancer settingby upregulating PTEN transcription.However, these studies were performed solely in breast cancer cell lines,leaving the speculation that these observations are cancer-type dependent. The gene discussed is PTEN; the disease is neoplasm.